LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

LLY

800.77

-0.47%↓

UNH

537.55

-0.92%↓

JNJ

151.14

+0.33%↑

ABBV

175.17

+0.23%↑

NVO

83.98

-1.12%↓

Search

Travere Therapeutics Inc

Abierto

20.16 -3.12

Resumen

Variación precio

24h

Actual

Mínimo

19.7

Máximo

21.35

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+35.31 upside

Dividendos

By Dow Jones

Próximas Ganancias

13 feb 2025

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

Travere Therapeutics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 ene 2025, 21:55 UTC

Ganancias

Stryker Sees Further Organic Sales Growth in 2025

28 ene 2025, 21:46 UTC

Adquisiciones, fusiones, absorciones

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

28 ene 2025, 21:29 UTC

Principales Movimientos del Mercado

NextEra Energy Shares Fall After XPLR Ceases Distributions

28 ene 2025, 23:54 UTC

Ganancias

Starbucks Earnings and Store Sales Fall, but CEO Upbeat on Turnaround -- 2nd Update

28 ene 2025, 23:49 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

28 ene 2025, 23:47 UTC

Charlas de Mercado

Nikkei May Rise After U.S. Tech Shares Rebound on Wall Street -- Market Talk

28 ene 2025, 23:17 UTC

Charlas de Mercado
Ganancias

Global Equities Roundup: Market Talk

28 ene 2025, 23:17 UTC

Charlas de Mercado
Ganancias

Boeing Sentiment Could Be Improving Despite Cut to Cash Outlook -- Market Talk

28 ene 2025, 22:50 UTC

Charlas de Mercado

DeepSeek Could Attract More Small Companies to AI, Mark Cuban Says -- Market Talk

28 ene 2025, 22:30 UTC

Principales Noticias

Pork Giant Smithfield Returns to U.S. Stock Market -- Update

28 ene 2025, 22:23 UTC

Principales Noticias

White House Spending Freeze Tries to Flip Script on Busted Budget Process -- 2nd Update

28 ene 2025, 22:05 UTC

Ganancias

Ashland 1Q Adj EPS 28c >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland 1Q Sales $405M >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

28 ene 2025, 22:03 UTC

Ganancias

Ashland 1Q Loss/Shr $3.50 >ASH

28 ene 2025, 21:57 UTC

Ganancias

Amazon Stock Sets a Record. Analysts Expect More Gains. -- Barrons.com

28 ene 2025, 21:56 UTC

Principales Noticias

White House Orders Pause of Federal Financial Assistance Programs -- 5th Update

28 ene 2025, 21:53 UTC

Principales Noticias
Ganancias

Starbucks Earnings and Store Sales Fall, but CEO Upbeat on Turnaround -- Update

28 ene 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

28 ene 2025, 21:41 UTC

Principales Noticias

Earnings Are Tech's Next Chance to Push Back on DeepSeek Worries -- Barrons.com

28 ene 2025, 21:36 UTC

Ganancias

Starbucks Earnings Beat Expectations. The Firm Is "Moving Quickly," Says CEO. -- Barrons.com

28 ene 2025, 21:25 UTC

Ganancias

Chubb Ltd 4Q Tangible Book Value Per Shr $100.38 >CB

28 ene 2025, 21:25 UTC

Ganancias

Chubb Ltd 4Q Book Value Per Shr $159.77

28 ene 2025, 21:22 UTC

Ganancias

Boeing Confirms Its Bad Earnings. Why the Stock Is Higher. -- Barrons.com

28 ene 2025, 21:18 UTC

Ganancias

GM Earnings Beat Expectations. Why the Stock Is Getting Crushed. -- Barrons.com

28 ene 2025, 21:18 UTC

Ganancias

Chubb Ltd 4Q P&C Combined Ratio 85.7%

28 ene 2025, 21:17 UTC

Ganancias

Chubb 4Q Consolidated Net Premiums Written $12.1 B

28 ene 2025, 21:16 UTC

Principales Noticias

Nasdaq Gains 2% After $1 Trillion DeepSeek Rout -- WSJ

28 ene 2025, 21:15 UTC

Ganancias

Chubb Ltd 4Q EPS $6.33 >CB

Comparación entre iguales

Cambio de precio

Travere Therapeutics Inc Esperado

Precio Objetivo

By TipRanks

35.31% repunte

Estimación a 12 meses

Media 28.55 USD  35.31%

Máximo 45 USD

Mínimo 22 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Travere Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

14 ratings

12

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

18.4525 / 21.56Soporte y Resistencia

Corto Plazo

Very Strong Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Weak Bullish Evidence

Finanzas

$